Zobrazeno 1 - 9
of 9
pro vyhledávání: ''
Autor:
Gustavo Laine Araújo de Oliveira, Mariângela Leal Cherchiglia, Francisco de Assis Acurcio, Anderson Lourenço da Silva, Eli Iola Gurgel Andrade, Alessandra Maciel Almeida
Publikováno v:
Value in Health. 14(5):S24-S28
Objective To perform a cost-effectiveness evaluation from the perspective of the Brazilian National Health System of alternatives strategies (i.e., conventional interferon, pegylated interferon, and lamivudine) for the treatment of patients with chro
Publikováno v:
Value in Health. 12(7)
Publikováno v:
Value in Health. 8(3)
Publikováno v:
Value in Health. 8(3)
Publikováno v:
Value in Health. 9:A300-A301
Publikováno v:
Value in Health. 9(6):A301-A302
• Conclusions To assess the economic and clinical impact of the use of peginterferon α-2a (40KD) versus LAM for the treatment of HBeAg-negative CHB and versus IFN for the treatment of HBeAg-positive CHB disease in Italy. • Objective Chronic Hepa
Publikováno v:
Value in Health. 9:A44
Publikováno v:
Value in Health. (7):A266
Publikováno v:
Value in Health. (6):A241